Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Genprex, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 49 | 47 | −2 |
| Shares | 5.89M | 7.46M | +1.57M (+26.7%) |
| Value | $15.8M | $9.78M | −$6.03M (−38.1%) |
New holders (8)
Institutions that held Genprex, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 438,874 | $575.0K | 0.08% |
| Two Sigma Investments, LP | 72,290 | $95.0K | 0.00% |
| Two Sigma Securities, LLC | 31,737 | $42.0K | 0.01% |
| Goldman Sachs Group Inc | 22,387 | $29.0K | 0.00% |
| Two Sigma Advisers, LP | 18,800 | $25.0K | 0.00% |
| ExodusPoint Capital Management, LP | 11,900 | $16.0K | 0.00% |
| National Bank of Canada | 850 | $1.00K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K | 0.00% |
Sold out (10)
Institutions that held Genprex, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ergoteles LLC | 74,569 | $200.0K |
| HRT Financial LP | 68,588 | $183.0K |
| Simplex Trading, LLC | 28,657 | $96.0K |
| HighTower Advisors, LLC | 26,000 | $70.0K |
| Wolverine Trading, LLC | 23,252 | $62.0K |
| B. Riley Wealth Management, Inc. | 16,750 | $45.0K |
| Meeder Asset Management Inc | 10,591 | $29.0K |
| Harbour Investments, Inc. | 2,077 | $6.00K |
| Nisa Investment Advisors, LLC | 2,400 | $6.00K |
| Steward Partners Investment Advisory, LLC | 1,500 | $4.00K |